CYNO Cynosure - Class A (MM)

Presentation to be Webcast Live on November 28 WESTFORD, Mass., Nov. 20 /PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that its senior management will participate in the Lazard Capital Markets Third Annual Life Sciences Conference in New York City. The company's presentation will be webcast live over the Internet beginning at 10:30 a.m. ET Tuesday, November 28. President and Chief Executive Officer Michael Davin and Chief Financial Officer Timothy Baker expect to discuss Cynosure's business outlook, growth strategy and recent financial results. To access the webcast, visit the "Investors" section of Cynosure's website, http://www.cynosurelaser.com/, and click on "Events." For those unable to listen to the live webcast, a replay will be available for 30 days on the Company's website. About Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosurelaser.com/. Contact: Scott Solomon Vice President Sharon Merrill Associates, Inc. 617-542-5300 DATASOURCE: Cynosure, Inc. CONTACT: Scott Solomon, Vice President of Sharon Merrill Associates, Inc., +1-617-542-5300, Web site: http://www.cynosurelaser.com/

Copyright